Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008–2014

Details

• Alternative Title:
  Vaccine
• Personal Author:
  Rodgers, Loren ; Pabst, Laura J ; Chaves, Sandra S
• Description:
  The Advisory Committee on Immunization Practices (ACIP) recommends annual influenza vaccination for all persons in the United States aged ≥6 months. On June 25, 2014, ACIP preferentially recommended live attenuated influenza vaccine (LAIV) for healthy children aged 2-8 years. Little is known about national LAIV uptake. To determine uptake of LAIV relative to inactivated influenza vaccine, we analyzed vaccination records from six immunization information system sentinel sites (approximately 10% of US population). LAIV usage increased over time in all sites. Among children 2-8 years of age vaccinated for influenza, exclusive LAIV usage in the collective sentinel site area increased from 20.1% (2008-09 season) to 38.0% (2013-14). During 2013-14, at least half of vaccinated children received LAIV in Minnesota (50.0%) and North Dakota (55.5%). Increasing LAIV usage suggests formulation acceptability, and this preexisting trend offers a favorable context for implementation of ACIP's preferential recommendation.
• Subjects:
  Article Child Child, Preschool Female Humans Immunization Information Systems Influenza, Human Influenza Vaccines Male Vaccination Vaccines, Attenuated

  More +
• Source:
  Vaccine. 33(1):22-24.
• Pubmed ID:
  25448098
• Pubmed Central ID:
  PMC5845854
• Document Type:
  Journal Article
• Funding:
  CC999999/Intramural CDC HHS/United States
• Place as Subject:
  United States
• Volume:
  33
• Issue:
  1
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:75a5c421adc9c6c910afa79cdb3f845b9c39f8a59db7b333ec5300764fa4a31d
• Download URL:
  https://stacks.cdc.gov/view/cdc/52448/cdc_52448_DS1.pdf
• File Type:
  [PDF - 151.44 KB ]